Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
27th March 2026 Uncategorised 0Rocket has announced that the FDA signed off on an accelerated approval for its hematopoietic stem cell-based gene therapy, Kresladi, also known as marnetegragene autotemcel, to treat certain children with severe leukocyte adhesion deficiency-1.
More: Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
Source: fierce